Jaren Landen
Chief Clinical Dev. Officer · CASSAVA SCIENCES INC
Individual
- 2024
- Nov 20, 2024
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jaren Landen files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Richard Barry - $972K in SAVA purchases and sales in the last 12 months
- Robert Eugene Anderson Jr. - $25K in SAVA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jaren Landen?
Jaren Landen is a corporate insider, tracked as Chief Clinical Dev. Officer of CASSAVA SCIENCES INC (SAVA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Jaren Landen last file a Form 4?
The only primary Form 4 on record is dated 20 November 2024.